Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Current Taxes (2019 - 2022)

ADC Therapeutics has reported Current Taxes over the past 4 years, most recently at $799000.0 for Q2 2022.

  • Quarterly results put Current Taxes at $799000.0 for Q2 2022, up 237.13% from a year ago — trailing twelve months through Jun 2022 was $799000.0 (up 237.13% YoY), and the annual figure for FY2021 was $3754.0, up 2419.46%.
  • Current Taxes reached $799000.0 in Q2 2022 per ADCT's latest filing, down from $6.4 million in the prior quarter.
  • Across five years, Current Taxes topped out at $6.4 million in Q1 2022 and bottomed at $52.0 in Q4 2019.
  • Median Current Taxes over the past 4 years was $3754.0 (2021), compared with a mean of $850799.3.
  • The largest annual shift saw Current Taxes surged 186.54% in 2020 before it soared 160035.14% in 2021.
  • Over 4 years, Current Taxes stood at $52.0 in 2019, then soared by 186.54% to $149.0 in 2020, then soared by 2419.46% to $3754.0 in 2021, then soared by 21183.96% to $799000.0 in 2022.
  • Business Quant data shows Current Taxes for ADCT at $799000.0 in Q2 2022, $6.4 million in Q1 2022, and $3754.0 in Q4 2021.